APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infectious Bursal Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Infectious Bursal Disease Vaccine Market Analysis and Forecast 2026-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchInfectious Bursal Disease Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Infectious Bursal Disease Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Infectious Bursal Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infectious Bursal Disease Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Infectious Bursal Disease Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Infectious Bursal Disease Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Infectious Bursal Disease Vaccine include Shandong Lvdu Biological Technology Co., Ltd., Ruipu Biopharmaceutical Co., Ltd., Qingdao Yibang Biological Engineering Co., Ltd., Plyco Bioengineering Co., Ltd., Merck, Harbin Pharmaceutical Group Biological Vaccine Co., Ltd., Zoetis, Elanco and Ceva, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Infectious Bursal Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Infectious Bursal Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Infectious Bursal Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Infectious Bursal Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Infectious Bursal Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Infectious Bursal Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.

Infectious Bursal Disease Vaccine Segment by Company

Shandong Lvdu Biological Technology Co., Ltd.

Ruipu Biopharmaceutical Co., Ltd.

Qingdao Yibang Biological Engineering Co., Ltd.

Plyco Bioengineering Co., Ltd.

Merck

Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Zoetis

Elanco

Ceva

Boehringer Ingelheim

Infectious Bursal Disease Vaccine Segment by Type

Live

Inactivated

Infectious Bursal Disease Vaccine Segment by Application

Veterinary Pharmacy

Online Sale

Others

Infectious Bursal Disease Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infectious Bursal Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infectious Bursal Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infectious Bursal Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Infectious Bursal Disease Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Infectious Bursal Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infectious Bursal Disease Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Major Manufacturers Table 3. Inactivated Major Manufacturers Table 4. Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Veterinary Pharmacy Major Manufacturers Table 6. Online Sale Major Manufacturers Table 7. Others Major Manufacturers Table 8. Infectious Bursal Disease Vaccine Industry Trends Table 9. Infectious Bursal Disease Vaccine Industry Drivers Table 10. Infectious Bursal Disease Vaccine Industry Opportunities and Challenges Table 11. Infectious Bursal Disease Vaccine Industry Restraints Table 12. Global Infectious Bursal Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Infectious Bursal Disease Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Infectious Bursal Disease Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Infectious Bursal Disease Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Infectious Bursal Disease Vaccine Sales by Region (2021-2026) & (K Units) Table 19. Global Infectious Bursal Disease Vaccine Sales by Region (2027-2032) & (K Units) Table 20. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Infectious Bursal Disease Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Infectious Bursal Disease Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Infectious Bursal Disease Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Infectious Bursal Disease Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Infectious Bursal Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Infectious Bursal Disease Vaccine Manufacturers, Product Type & Application Table 30. Global Infectious Bursal Disease Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Infectious Bursal Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Infectious Bursal Disease Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Infectious Bursal Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Infectious Bursal Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Infectious Bursal Disease Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 40. Global Infectious Bursal Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 41. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Infectious Bursal Disease Vaccine Price by Type (2021-2026) & (US$/Unit) Table 44. Global Infectious Bursal Disease Vaccine Price by Type (2027-2032) & (US$/Unit) Table 45. Global Infectious Bursal Disease Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Infectious Bursal Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Infectious Bursal Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Infectious Bursal Disease Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Infectious Bursal Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 53. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Infectious Bursal Disease Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Infectious Bursal Disease Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. Shandong Lvdu Biological Technology Co., Ltd. Company Information Table 58. Shandong Lvdu Biological Technology Co., Ltd. Business Overview Table 59. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 61. Shandong Lvdu Biological Technology Co., Ltd. Recent Development Table 62. Ruipu Biopharmaceutical Co., Ltd. Company Information Table 63. Ruipu Biopharmaceutical Co., Ltd. Business Overview Table 64. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 66. Ruipu Biopharmaceutical Co., Ltd. Recent Development Table 67. Qingdao Yibang Biological Engineering Co., Ltd. Company Information Table 68. Qingdao Yibang Biological Engineering Co., Ltd. Business Overview Table 69. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 71. Qingdao Yibang Biological Engineering Co., Ltd. Recent Development Table 72. Plyco Bioengineering Co., Ltd. Company Information Table 73. Plyco Bioengineering Co., Ltd. Business Overview Table 74. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 76. Plyco Bioengineering Co., Ltd. Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck Infectious Bursal Disease Vaccine Product Portfolio Table 81. Merck Recent Development Table 82. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information Table 83. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview Table 84. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 86. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Development Table 87. Zoetis Company Information Table 88. Zoetis Business Overview Table 89. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Zoetis Infectious Bursal Disease Vaccine Product Portfolio Table 91. Zoetis Recent Development Table 92. Elanco Company Information Table 93. Elanco Business Overview Table 94. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Elanco Infectious Bursal Disease Vaccine Product Portfolio Table 96. Elanco Recent Development Table 97. Ceva Company Information Table 98. Ceva Business Overview Table 99. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Ceva Infectious Bursal Disease Vaccine Product Portfolio Table 101. Ceva Recent Development Table 102. Boehringer Ingelheim Company Information Table 103. Boehringer Ingelheim Business Overview Table 104. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolio Table 106. Boehringer Ingelheim Recent Development Table 107. North America Infectious Bursal Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Infectious Bursal Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 110. North America Infectious Bursal Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 111. North America Infectious Bursal Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 112. North America Infectious Bursal Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 113. North America Infectious Bursal Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Infectious Bursal Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 116. North America Infectious Bursal Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 117. North America Infectious Bursal Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 118. North America Infectious Bursal Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 119. North America Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Infectious Bursal Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. North America Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 124. North America Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 125. North America Infectious Bursal Disease Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 126. North America Infectious Bursal Disease Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 127. United States Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Canada Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 129. Europe Infectious Bursal Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Infectious Bursal Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 132. Europe Infectious Bursal Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 133. Europe Infectious Bursal Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 134. Europe Infectious Bursal Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 135. Europe Infectious Bursal Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Infectious Bursal Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 138. Europe Infectious Bursal Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 139. Europe Infectious Bursal Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 140. Europe Infectious Bursal Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Europe Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe Infectious Bursal Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. Europe Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 146. Europe Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 147. Europe Infectious Bursal Disease Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 148. Europe Infectious Bursal Disease Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 149. Germany Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 150. France Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 151. U.K. Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 152. Italy Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 154. China Infectious Bursal Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 155. China Infectious Bursal Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 156. China Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 157. China Infectious Bursal Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 158. China Infectious Bursal Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 159. China Infectious Bursal Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 160. China Infectious Bursal Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 161. China Infectious Bursal Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 162. China Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 163. China Infectious Bursal Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 164. China Infectious Bursal Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 165. China Infectious Bursal Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Asia Infectious Bursal Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Infectious Bursal Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 169. Asia Infectious Bursal Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 170. Asia Infectious Bursal Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 171. Asia Infectious Bursal Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 172. Asia Infectious Bursal Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Infectious Bursal Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 175. Asia Infectious Bursal Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 176. Asia Infectious Bursal Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 177. Asia Infectious Bursal Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 178. Asia Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Infectious Bursal Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 182. Asia Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 183. Asia Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 184. Asia Infectious Bursal Disease Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 185. Asia Infectious Bursal Disease Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 186. Japan Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 187. South Korea Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 188. India Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Australia Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 190. China Taiwan Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Infectious Bursal Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Infectious Bursal Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 195. SAMEA Infectious Bursal Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 196. SAMEA Infectious Bursal Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 197. SAMEA Infectious Bursal Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 198. SAMEA Infectious Bursal Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Infectious Bursal Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 201. SAMEA Infectious Bursal Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 202. SAMEA Infectious Bursal Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 203. SAMEA Infectious Bursal Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 204. SAMEA Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Infectious Bursal Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 208. SAMEA Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 209. SAMEA Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 210. SAMEA Infectious Bursal Disease Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 211. SAMEA Infectious Bursal Disease Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 212. Brazil Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Argentina Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Chile Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Colombia Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Peru Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Israel Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 219. UAE Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Turkey Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Iran Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Egypt Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Infectious Bursal Disease Vaccine Distributors List Table 226. Infectious Bursal Disease Vaccine Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Infectious Bursal Disease Vaccine Image Figure 2. Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infectious Bursal Disease Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Image Figure 5. Inactivated Image Figure 6. Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Infectious Bursal Disease Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Veterinary Pharmacy Image Figure 9. Online Sale Image Figure 10. Others Image Figure 11. Global Infectious Bursal Disease Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Infectious Bursal Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Infectious Bursal Disease Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Infectious Bursal Disease Vaccine Sales (2021-2032) & (K Units) Figure 17. Global Infectious Bursal Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Infectious Bursal Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. Europe Infectious Bursal Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. China Infectious Bursal Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Infectious Bursal Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Infectious Bursal Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. Global Infectious Bursal Disease Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Infectious Bursal Disease Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Infectious Bursal Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Infectious Bursal Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Infectious Bursal Disease Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Infectious Bursal Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Infectious Bursal Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Infectious Bursal Disease Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Infectious Bursal Disease Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Infectious Bursal Disease Vaccine Sales Share by Type (2021-2032) Figure 41. North America Infectious Bursal Disease Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Infectious Bursal Disease Vaccine Sales Share by Application (2021-2032) Figure 43. North America Infectious Bursal Disease Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Infectious Bursal Disease Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Infectious Bursal Disease Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Infectious Bursal Disease Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Infectious Bursal Disease Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Infectious Bursal Disease Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Infectious Bursal Disease Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Infectious Bursal Disease Vaccine Sales Share by Country (2021-2032) Figure 51. China Infectious Bursal Disease Vaccine Revenue Share by Type (2021-2032) Figure 52. China Infectious Bursal Disease Vaccine Sales Share by Type (2021-2032) Figure 53. China Infectious Bursal Disease Vaccine Revenue Share by Application (2021-2032) Figure 54. China Infectious Bursal Disease Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Infectious Bursal Disease Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Infectious Bursal Disease Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Infectious Bursal Disease Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Infectious Bursal Disease Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Infectious Bursal Disease Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Infectious Bursal Disease Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Infectious Bursal Disease Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Infectious Bursal Disease Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Infectious Bursal Disease Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Infectious Bursal Disease Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Infectious Bursal Disease Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Infectious Bursal Disease Vaccine Sales Share by Country (2021-2032) Figure 67. Infectious Bursal Disease Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Infectious Bursal Disease Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Live
  • Inactivated
Applications
  • Veterinary Pharmacy
  • Online Sale
  • Others
Companies covered
  • Shandong Lvdu Biological Technology Co., Ltd.
  • Ruipu Biopharmaceutical Co., Ltd.
  • Qingdao Yibang Biological Engineering Co., Ltd.
  • Plyco Bioengineering Co., Ltd.
  • Merck
  • Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  • Zoetis
  • Elanco
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Infectious Bursal Disease Vaccine Market by Type
  3. 1.2.1 Global Infectious Bursal Disease Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live
  5. 1.2.3 Inactivated
  6. 1.3 Infectious Bursal Disease Vaccine Market by Application
  7. 1.3.1 Global Infectious Bursal Disease Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Veterinary Pharmacy
  9. 1.3.3 Online Sale
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Infectious Bursal Disease Vaccine Market Dynamics
  1. 2.1 Infectious Bursal Disease Vaccine Industry Trends
  2. 2.2 Infectious Bursal Disease Vaccine Industry Drivers
  3. 2.3 Infectious Bursal Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Infectious Bursal Disease Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Infectious Bursal Disease Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Infectious Bursal Disease Vaccine Revenue by Region
  3. 3.2.1 Global Infectious Bursal Disease Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Infectious Bursal Disease Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Infectious Bursal Disease Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Infectious Bursal Disease Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Infectious Bursal Disease Vaccine Sales by Region
  9. 3.4.1 Global Infectious Bursal Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Infectious Bursal Disease Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Infectious Bursal Disease Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Infectious Bursal Disease Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Infectious Bursal Disease Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Infectious Bursal Disease Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Infectious Bursal Disease Vaccine Sales by Manufacturers
  6. 4.2.1 Global Infectious Bursal Disease Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Infectious Bursal Disease Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Infectious Bursal Disease Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Infectious Bursal Disease Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Infectious Bursal Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Infectious Bursal Disease Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Infectious Bursal Disease Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Infectious Bursal Disease Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Infectious Bursal Disease Vaccine Tier 1, Tier 2, and Tier 3
5 Infectious Bursal Disease Vaccine Market by Type
  1. 5.1 Global Infectious Bursal Disease Vaccine Revenue by Type
  2. 5.1.1 Global Infectious Bursal Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Infectious Bursal Disease Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Infectious Bursal Disease Vaccine Sales by Type
  6. 5.2.1 Global Infectious Bursal Disease Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Infectious Bursal Disease Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Infectious Bursal Disease Vaccine Price by Type
6 Infectious Bursal Disease Vaccine Market by Application
  1. 6.1 Global Infectious Bursal Disease Vaccine Revenue by Application
  2. 6.1.1 Global Infectious Bursal Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Infectious Bursal Disease Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Infectious Bursal Disease Vaccine Sales by Application
  6. 6.2.1 Global Infectious Bursal Disease Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Infectious Bursal Disease Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Infectious Bursal Disease Vaccine Price by Application
7 Company Profiles
  1. 7.1 Shandong Lvdu Biological Technology Co., Ltd.
  2. 7.1.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information
  3. 7.1.2 Shandong Lvdu Biological Technology Co., Ltd. Business Overview
  4. 7.1.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  6. 7.1.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments
  7. 7.2 Ruipu Biopharmaceutical Co., Ltd.
  8. 7.2.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Ruipu Biopharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  12. 7.2.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Qingdao Yibang Biological Engineering Co., Ltd.
  14. 7.3.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information
  15. 7.3.2 Qingdao Yibang Biological Engineering Co., Ltd. Business Overview
  16. 7.3.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  18. 7.3.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments
  19. 7.4 Plyco Bioengineering Co., Ltd.
  20. 7.4.1 Plyco Bioengineering Co., Ltd. Company Information
  21. 7.4.2 Plyco Bioengineering Co., Ltd. Business Overview
  22. 7.4.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  24. 7.4.5 Plyco Bioengineering Co., Ltd. Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Infectious Bursal Disease Vaccine Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  32. 7.6.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
  33. 7.6.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview
  34. 7.6.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  36. 7.6.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
  37. 7.7 Zoetis
  38. 7.7.1 Zoetis Company Information
  39. 7.7.2 Zoetis Business Overview
  40. 7.7.3 Zoetis Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Zoetis Infectious Bursal Disease Vaccine Product Portfolio
  42. 7.7.5 Zoetis Recent Developments
  43. 7.8 Elanco
  44. 7.8.1 Elanco Company Information
  45. 7.8.2 Elanco Business Overview
  46. 7.8.3 Elanco Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Elanco Infectious Bursal Disease Vaccine Product Portfolio
  48. 7.8.5 Elanco Recent Developments
  49. 7.9 Ceva
  50. 7.9.1 Ceva Company Information
  51. 7.9.2 Ceva Business Overview
  52. 7.9.3 Ceva Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ceva Infectious Bursal Disease Vaccine Product Portfolio
  54. 7.9.5 Ceva Recent Developments
  55. 7.10 Boehringer Ingelheim
  56. 7.10.1 Boehringer Ingelheim Company Information
  57. 7.10.2 Boehringer Ingelheim Business Overview
  58. 7.10.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolio
  60. 7.10.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Infectious Bursal Disease Vaccine Market Size by Type
  2. 8.1.1 North America Infectious Bursal Disease Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Infectious Bursal Disease Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Infectious Bursal Disease Vaccine Price by Type (2021-2032)
  5. 8.2 North America Infectious Bursal Disease Vaccine Market Size by Application
  6. 8.2.1 North America Infectious Bursal Disease Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Infectious Bursal Disease Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Infectious Bursal Disease Vaccine Price by Application (2021-2032)
  9. 8.3 North America Infectious Bursal Disease Vaccine Market Size by Country
  10. 8.3.1 North America Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Infectious Bursal Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Infectious Bursal Disease Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Infectious Bursal Disease Vaccine Market Size by Type
  2. 9.1.1 Europe Infectious Bursal Disease Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Infectious Bursal Disease Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Infectious Bursal Disease Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Infectious Bursal Disease Vaccine Market Size by Application
  6. 9.2.1 Europe Infectious Bursal Disease Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Infectious Bursal Disease Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Infectious Bursal Disease Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Infectious Bursal Disease Vaccine Market Size by Country
  10. 9.3.1 Europe Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Infectious Bursal Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Infectious Bursal Disease Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Infectious Bursal Disease Vaccine Market Size by Type
  2. 10.1.1 China Infectious Bursal Disease Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Infectious Bursal Disease Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Infectious Bursal Disease Vaccine Price by Type (2021-2032)
  5. 10.2 China Infectious Bursal Disease Vaccine Market Size by Application
  6. 10.2.1 China Infectious Bursal Disease Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Infectious Bursal Disease Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Infectious Bursal Disease Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Infectious Bursal Disease Vaccine Market Size by Type
  2. 11.1.1 Asia Infectious Bursal Disease Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Infectious Bursal Disease Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Infectious Bursal Disease Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Infectious Bursal Disease Vaccine Market Size by Application
  6. 11.2.1 Asia Infectious Bursal Disease Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Infectious Bursal Disease Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Infectious Bursal Disease Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Infectious Bursal Disease Vaccine Market Size by Country
  10. 11.3.1 Asia Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Infectious Bursal Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Infectious Bursal Disease Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Infectious Bursal Disease Vaccine Market Size by Type
  2. 12.1.1 SAMEA Infectious Bursal Disease Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Infectious Bursal Disease Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Infectious Bursal Disease Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Infectious Bursal Disease Vaccine Market Size by Application
  6. 12.2.1 SAMEA Infectious Bursal Disease Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Infectious Bursal Disease Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Infectious Bursal Disease Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Infectious Bursal Disease Vaccine Market Size by Country
  10. 12.3.1 SAMEA Infectious Bursal Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Infectious Bursal Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Infectious Bursal Disease Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Infectious Bursal Disease Vaccine Value Chain Analysis
  2. 13.1.1 Infectious Bursal Disease Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Infectious Bursal Disease Vaccine Production Mode & Process
  6. 13.2 Infectious Bursal Disease Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Infectious Bursal Disease Vaccine Distributors
  9. 13.2.3 Infectious Bursal Disease Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst